379 related articles for article (PubMed ID: 16089119)
21. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
[TBL] [Abstract][Full Text] [Related]
22. False-negative sentinel lymph node biopsy.
van Wely BJ; Smidt ML; de Kievit IM; Wauters CA; Strobbe LJ
Br J Surg; 2008 Nov; 95(11):1352-5. PubMed ID: 18844270
[TBL] [Abstract][Full Text] [Related]
23. The natural history of breast carcinoma in the elderly: implications for screening and treatment.
Singh R; Hellman S; Heimann R
Cancer; 2004 May; 100(9):1807-13. PubMed ID: 15112260
[TBL] [Abstract][Full Text] [Related]
24. A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer.
Konstantiniuk P; Schrenk P; Reitsamer R; Koeberle-Wuehrer R; Tausch C; Roka S; Riedl O; Poestlberger S; Hecke D; Janauer M; Haid A
Breast; 2007 Oct; 16(5):520-6. PubMed ID: 17566737
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer.
Katz A; Gage I; Evans S; Shaffer M; Fleury T; Smith FP; Flax R; Drogula C; Petrucci P; Magnant C
Am J Surg; 2006 Jun; 191(6):761-6. PubMed ID: 16720145
[TBL] [Abstract][Full Text] [Related]
26. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration.
van der Ploeg IM; Kroon BB; Antonini N; Valdés Olmos RA; Rutgers EJ; Nieweg OE
Ann Surg Oncol; 2008 Apr; 15(4):1025-31. PubMed ID: 18219534
[TBL] [Abstract][Full Text] [Related]
27. HPV status in sentinel nodes might be a prognostic factor in cervical cancer.
Lee YS; Rhim CC; Lee HN; Lee KH; Park JS; Namkoong SE
Gynecol Oncol; 2007 May; 105(2):351-7. PubMed ID: 17275890
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma.
Esteva FJ; Sahin AA; Smith TL; Yang Y; Pusztai L; Nahta R; Buchholz TA; Buzdar AU; Hortobagyi GN; Bacus SS
Cancer; 2004 Feb; 100(3):499-506. PubMed ID: 14745865
[TBL] [Abstract][Full Text] [Related]
29. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.
; Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
J Clin Oncol; 2006 May; 24(15):2268-75. PubMed ID: 16618947
[TBL] [Abstract][Full Text] [Related]
30. Sentinel node biopsy in larger or multifocal breast cancers: to do or not to do.
Behm EC; Buckingham JM
ANZ J Surg; 2008 Mar; 78(3):151-7. PubMed ID: 18269478
[TBL] [Abstract][Full Text] [Related]
31. Histopathologic characteristics of the primary tumor in breast cancer patients with isolated tumor cells of the sentinel node.
Hulvat M; Rajan P; Rajan E; Sarker S; Schermer C; Aranha G; Yao K
Surgery; 2008 Oct; 144(4):518-24; discussion 524. PubMed ID: 18847634
[TBL] [Abstract][Full Text] [Related]
32. Non-axillary breast cancer recurrences after sentinel node biopsy.
van Rijk MC; Nieweg OE; Valdés Olmos RA; Rutgers EJ; Hoefnagel CA; Kroon BB
J Surg Oncol; 2005 Dec; 92(4):292-8. PubMed ID: 16299804
[TBL] [Abstract][Full Text] [Related]
33. Recurrence in the axilla after sentinel lymph node biopsy for breast cancer.
Salmon RJ; Bouillet TH; Lewis JS; Clough KB
Eur J Surg Oncol; 2002 Mar; 28(2):199. PubMed ID: 11884060
[No Abstract] [Full Text] [Related]
34. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.
Bilchik AJ; Hoon DS; Saha S; Turner RR; Wiese D; DiNome M; Koyanagi K; McCarter M; Shen P; Iddings D; Chen SL; Gonzalez M; Elashoff D; Morton DL
Ann Surg; 2007 Oct; 246(4):568-75; discussion 575-7. PubMed ID: 17893493
[TBL] [Abstract][Full Text] [Related]
36. Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study.
Bergkvist L; de Boniface J; Jönsson PE; Ingvar C; Liljegren G; Frisell J;
Ann Surg; 2008 Jan; 247(1):150-6. PubMed ID: 18156935
[TBL] [Abstract][Full Text] [Related]
37. Axillary recurrence after negative sentinel lymph node biopsy: frequency and factors influencing recurrence on the long term.
Sanli I; Lemaire BM; Muller AJ; van Kleffens HJ; Van Poll-Franse LV; van Dijk M
Breast J; 2009; 15(3):236-41. PubMed ID: 19645777
[TBL] [Abstract][Full Text] [Related]
38. The effect of sentinel lymph node biopsy on the Nottingham Prognostic Index in breast cancer patients.
Cserni G
J R Coll Surg Edinb; 2001 Aug; 46(4):208-12. PubMed ID: 11523712
[TBL] [Abstract][Full Text] [Related]
39. Management and outcomes of isolated axillary node recurrence in breast cancer.
Konkin DE; Tyldesley S; Kennecke H; Speers CH; Olivotto IA; Davis N
Arch Surg; 2006 Sep; 141(9):867-72; discussion 872-4. PubMed ID: 16983030
[TBL] [Abstract][Full Text] [Related]
40. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
